Academic
Publications
Targeting the neural cell adhesion molecule in cancer

Targeting the neural cell adhesion molecule in cancer,10.1016/j.canlet.2007.09.004,Cancer Letters,Markus Jensen,Frank Berthold

Targeting the neural cell adhesion molecule in cancer   (Citations: 15)
BibTex | RIS | RefWorks Download
NCAM is a tumour associated antigen expressed on small cell lung cancer, neuroblastoma, rhabdomyosarkoma, brain tumours, multiple myelomas and acute myeloid leukaemia. Constant and strong expression of NCAM is a prerequisite for the development of antibody-based immunotherapies. From the spectrum of existing anti-NCAM compounds, radioimmunoconjugates and immunotoxins represent the clinically most advanced and successful strategies. Here we provide an overview of the evolving field of anti-NCAM immunotherapy for cancer and discuss its indications and limitations.
Journal: Cancer Letters - CANCER LETT , vol. 258, no. 1, pp. 9-21, 2007
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: